|
|
Volumn 12, Issue 5, 2001, Pages 565-569
|
|
Lipid-lowering drugs and risk of myopathy: A population-based follow-up study
a
|
|
Author keywords
Fibrates; Lipid lowering drugs; Myopathy; Statins
|
|
Indexed keywords
ACIPIMOX;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BEZAFIBRATE;
CERIVASTATIN;
CIPROFIBRATE;
CLOFIBRATE;
COLESTIPOL;
COLESTYRAMINE;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
GEMFIBROZIL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NICOTINIC ACID;
PRAVASTATIN;
SIMVASTATIN;
ADULT;
AGED;
ARTICLE;
COHORT ANALYSIS;
CONTROLLED STUDY;
DATA BASE;
DRUG INDUCED DISEASE;
FEMALE;
FOLLOW UP;
GENERAL PRACTITIONER;
HUMAN;
HYPERLIPIDEMIA;
MAJOR CLINICAL STUDY;
MALE;
MUSCLE WEAKNESS;
MYALGIA;
MYOPATHY;
PHARMACOEPIDEMIOLOGY;
POPULATION RESEARCH;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK FACTOR;
UNITED KINGDOM;
ADULT;
AGED;
ANTILIPEMIC AGENTS;
BODY MASS INDEX;
CASE-CONTROL STUDIES;
FEMALE;
GREAT BRITAIN;
HUMANS;
HYPERLIPIDEMIAS;
INCIDENCE;
MALE;
MIDDLE AGED;
MUSCULAR DISEASES;
POPULATION SURVEILLANCE;
RISK;
|
|
EID: 0034887738
PISSN: 10443983
EISSN: None
Source Type: Journal
DOI: 10.1097/00001648-200109000-00017 Document Type: Article |
|
Times cited : (197)
|
|
References (12)
|
